Trial Profile
Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 May 2022
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Metoprolol
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 26 May 2022 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2020 Planned End Date changed from 1 Jun 2020 to 1 Jun 2025.
- 02 Nov 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Jun 2025.